Discontinuation of Commercialization of Gatiflo(gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan
September 30, 2008
Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Itaru Kojo), a wholly owned subsidiary of Kyorin Co., Ltd., and Dainippon Sumitomo Pharma Co., Ltd. (Osaka, President: Masayo Tada) announce that they have decided to voluntarily discontinue commercialization of Gatiflo® (gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan as of September 30, 2008.
Please see the PDF file below for details.
